SLP
Simulations Plus, Inc.
Price Chart
Latest Quote
$18.24
-0.01 (-0.05%)
Current Price
| Previous Close | $18.25 |
| Open | $18.23 |
| Day High | $18.29 |
| Day Low | $18.19 |
| Volume | 1,014,953 |
Stock Information
| Shares Outstanding | 20.21M |
| Total Debt | $508K |
| Cash Equivalents | $41.84M |
| Revenue | $80.53M |
| Net Income | $-62.79M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $368.55M |
| EPS (TTM) | $-3.12 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $327.22M |
| Sales | $80.53M |
| Income | $-62.79M |
| Book/sh | $6.62 |
| Cash/sh | $2.07 |
| Employees | 212 |
Financial Ratios
| Quick Ratio | 5.26 |
| Current Ratio | 5.47 |
| Debt/Eq | 0.38 |
| EPS Growth TTM | 47.50% |
Returns & Margins
| ROA | 3.81% |
| ROE | -38.84% |
| Gross Margin | 61.97% |
| Operating Margin | 23.18% |
| Profit Margin | -77.96% |
Ownership
| Insider Ownership | 17.21% |
| Institutional Ownership | 82.69% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 19.96 |
| PEG | 9.88 |
| P/S | 4.58 |
| P/B | 2.75 |
Analyst Data
| Recommendation | hold |
| Target Price | $17.25 |
Technical Indicators
| SMA20 | $16.50 |
| SMA50 | $15.26 |
| SMA200 | $15.71 |
| RSI | 58.98 |
| ATR | 0.8586 |
| Shares Float | 16.73M |
| Short Float | 9.55% |
| Short Ratio | 3.81 |
| Volatility | 1.32 |
| Rel Volume | 2.53 |
Performance History
| Week | +10.61% |
| Month | +29.36% |
| Quarter | +55.76% |
| 6 Months | -3.29% |
| YTD | +0.72% |
| Year | -0.44% |
| 3 Years | -60.64% |
| 5 Years | -66.03% |
| 10 Years | +172.77% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $18.24 | 1,045,300 |
| 2026-06-17 | $18.25 | 1,428,800 |
| 2026-06-16 | $18.24 | 2,174,600 |
| 2026-06-15 | $16.37 | 178,000 |
| 2026-06-12 | $16.32 | 160,700 |
| 2026-06-11 | $16.49 | 171,500 |
| 2026-06-10 | $15.94 | 172,900 |
| 2026-06-09 | $16.01 | 182,300 |
| 2026-06-08 | $15.91 | 184,000 |
| 2026-06-05 | $15.88 | 204,200 |
| 2026-06-04 | $16.65 | 148,900 |
| 2026-06-03 | $16.17 | 253,200 |
| 2026-06-02 | $16.77 | 198,100 |
| 2026-06-01 | $17.73 | 371,300 |
| 2026-05-29 | $17.11 | 260,800 |
| 2026-05-28 | $16.71 | 263,700 |
| 2026-05-27 | $15.55 | 187,100 |
| 2026-05-26 | $15.28 | 232,000 |
| 2026-05-22 | $15.37 | 171,300 |
| 2026-05-21 | $15.11 | 262,300 |
| 2026-05-20 | $14.47 | 194,900 |
| 2026-05-19 | $14.10 | 188,300 |
About Simulations Plus, Inc.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
đ° Latest News
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets
Simply Wall St. âĸ 2026-06-20T01:09:51Z
Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls
The Fly âĸ 2026-06-17T13:47:56Z
Altaris to acquire Simulations Plus in $375m all-cash deal
Hospital Management âĸ 2026-06-17T09:56:48Z
Sector Update: Tech Stocks Fall Tuesday Afternoon
MT Newswires âĸ 2026-06-16T17:31:07ZWhy Shares in Simulation Plus Soared Today
Motley Fool âĸ 2026-06-16T17:24:33ZDividend Investors: Don't Be Too Quick To Buy SLP Resources Berhad (KLSE:SLP) For Its Upcoming Dividend
Simply Wall St. âĸ 2026-06-11T23:50:36Z
Is It Too Late To Consider Buying Simulations Plus, Inc. (NASDAQ:SLP)?
Simply Wall St. âĸ 2026-05-29T10:11:49Z
This Analyst Just Made A Huge Upgrade To Their SLP Resources Berhad (KLSE:SLP) Earnings Forecasts
Simply Wall St. âĸ 2026-05-12T22:35:01Z
Do Options Traders Know Something About Simulations Plus Stock We Don't?
Zacks âĸ 2026-05-04T16:53:00Z
Badger Meter's Q1 Earnings & Revenues Miss Estimates, Stock Dips
Zacks âĸ 2026-04-20T14:04:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $32,958,000 | $26,862,000 | $11,630,000 | $10,822,000 |
| Cost Of Revenue | $32,958,000 | $26,862,000 | $11,630,000 | $10,822,000 |
| Total Revenue | $79,179,000 | $70,013,000 | $59,577,000 | $53,906,000 |
| Operating Revenue | $79,179,000 | $70,013,000 | $59,577,000 | $53,906,000 |
| Expenses | ||||
| Total Expenses | $72,687,000 | $63,882,000 | $50,352,000 | $38,995,000 |
| Other Income Expense | $-76,591,000 | $1,905,000 | $-1,661,000 | $-513,000 |
| Net Non Operating Interest Income Expense | $722,000 | $4,375,000 | $4,131,000 | $717,000 |
| Operating Expense | $39,729,000 | $37,020,000 | $38,722,000 | $28,173,000 |
| Selling And Marketing Expense | $11,904,000 | $8,915,000 | $6,558,000 | $4,879,000 |
| General And Administrative Expense | $20,941,000 | $22,351,000 | $27,660,000 | $20,086,000 |
| Interest Expense | - | - | $0 | $0 |
| Interest Expense Non Operating | - | - | $0 | $0 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-64,718,000 | $9,954,000 | $9,961,000 | $12,483,000 |
| Net Interest Income | $722,000 | $4,375,000 | $4,131,000 | $717,000 |
| Interest Income | $722,000 | $4,375,000 | $4,131,000 | $717,000 |
| Normalized Income | $6,741,403 | $8,426,190 | $11,376,172 | $12,908,790 |
| Net Income From Continuing And Discontinued Operation | $-64,718,000 | $9,954,000 | $9,961,000 | $12,483,000 |
| Total Operating Income As Reported | $-70,729,000 | $6,131,000 | $8,725,000 | $14,911,000 |
| Net Income Common Stockholders | $-64,718,000 | $9,954,000 | $9,961,000 | $12,483,000 |
| Net Income | $-64,718,000 | $9,954,000 | $9,961,000 | $12,483,000 |
| Net Income Including Noncontrolling Interests | $-64,718,000 | $9,954,000 | $9,961,000 | $12,483,000 |
| Net Income Continuous Operations | $-64,718,000 | $9,954,000 | $9,961,000 | $12,483,000 |
| Pretax Income | $-69,377,000 | $12,411,000 | $11,695,000 | $15,115,000 |
| Special Income Charges | $-76,604,000 | $1,639,000 | $-1,186,000 | $-282,000 |
| Interest Income Non Operating | $722,000 | $4,375,000 | $4,131,000 | $717,000 |
| Operating Income | $6,492,000 | $6,131,000 | $9,225,000 | $14,911,000 |
| Gross Profit | $46,221,000 | $43,151,000 | $47,947,000 | $43,084,000 |
| Per Share | ||||
| Diluted EPS | $-3.22 | $0.49 | $0.49 | $0.60 |
| Basic EPS | $-3.22 | $0.50 | $0.50 | $0.62 |
| Other | ||||
| Tax Effect Of Unusual Items | $-5,131,597 | $377,190 | $-245,828 | $-87,210 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $91,294,000 | $9,891,000 | $14,726,000 | $18,998,000 |
| Total Unusual Items | $-76,591,000 | $1,905,000 | $-1,661,000 | $-513,000 |
| Total Unusual Items Excluding Goodwill | $-76,591,000 | $1,905,000 | $-1,661,000 | $-513,000 |
| Reconciled Depreciation | $8,211,000 | $5,665,000 | $3,840,000 | $3,574,000 |
| EBITDA (Bullshit earnings) | $14,703,000 | $11,796,000 | $13,065,000 | $18,485,000 |
| EBIT | $6,492,000 | $6,131,000 | $9,225,000 | $14,911,000 |
| Diluted Average Shares | $20,101,000 | $20,301,000 | $20,465,000 | $20,749,000 |
| Basic Average Shares | $20,101,000 | $19,987,000 | $20,075,000 | $20,196,000 |
| Diluted NI Availto Com Stockholders | $-64,718,000 | $9,954,000 | $9,961,000 | $12,483,000 |
| Tax Provision | $-4,659,000 | $2,457,000 | $1,734,000 | $2,632,000 |
| Gain On Sale Of Ppe | $-23,000 | $0 | $-6,000 | $1,000 |
| Write Off | $77,221,000 | $0 | $500,000 | - |
| Restructuring And Mergern Acquisition | $-640,000 | $-1,639,000 | $680,000 | $283,000 |
| Gain On Sale Of Security | $13,000 | $266,000 | $-475,000 | $-231,000 |
| Research And Development | $6,884,000 | $5,754,000 | $4,504,000 | $3,208,000 |
| Selling General And Administration | $32,845,000 | $31,266,000 | $34,218,000 | $24,965,000 |
| Other Gand A | $20,941,000 | $22,351,000 | $27,660,000 | $20,086,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $51,874,000 | $27,514,000 | $118,081,000 | $139,147,000 |
| Total Assets | $131,936,000 | $196,639,000 | $186,101,000 | $188,382,000 |
| Total Non Current Assets | $80,387,000 | $157,298,000 | $55,729,000 | $41,592,000 |
| Other Non Current Assets | $1,399,000 | $542,000 | $425,000 | $439,000 |
| Non Current Deferred Assets | $4,774,000 | $0 | $1,438,000 | $0 |
| Non Current Deferred Taxes Assets | $4,774,000 | $0 | $1,438,000 | $0 |
| Goodwill And Other Intangible Assets | $72,927,000 | $154,917,000 | $51,948,000 | $39,101,000 |
| Other Intangible Assets | $29,210,000 | $58,839,000 | $32,849,000 | $26,180,000 |
| Current Assets | $51,549,000 | $39,341,000 | $130,372,000 | $146,790,000 |
| Other Current Assets | $7,702,000 | $7,753,000 | $3,904,000 | $3,377,000 |
| Prepaid Assets | $1,777,000 | $2,197,000 | $804,000 | $1,391,000 |
| Receivables | $9,717,000 | $9,136,000 | $10,201,000 | $13,787,000 |
| Accounts Receivable | $9,717,000 | $9,136,000 | $10,201,000 | $13,787,000 |
| Allowance For Doubtful Accounts Receivable | $-187,000 | $-149,000 | $-46,000 | $-12,000 |
| Gross Accounts Receivable | $9,904,000 | $9,285,000 | $10,247,000 | $13,799,000 |
| Cash Cash Equivalents And Short Term Investments | $32,353,000 | $20,255,000 | $115,463,000 | $128,235,000 |
| Cash And Cash Equivalents | $30,853,000 | $10,311,000 | $57,523,000 | $51,567,000 |
| Other Receivables | - | - | - | - |
| Debt | ||||
| Total Debt | $616,000 | $1,006,000 | $1,197,000 | $1,404,000 |
| Long Term Debt And Capital Lease Obligation | $410,000 | $531,000 | $755,000 | $943,000 |
| Current Debt And Capital Lease Obligation | $206,000 | $475,000 | $442,000 | $461,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,135,000 | $14,208,000 | $16,072,000 | $10,134,000 |
| Total Non Current Liabilities Net Minority Interest | $410,000 | $2,139,000 | $4,085,000 | $2,399,000 |
| Non Current Deferred Liabilities | $0 | $1,608,000 | $0 | $1,456,000 |
| Non Current Deferred Taxes Liabilities | $0 | $1,608,000 | $0 | $1,456,000 |
| Current Liabilities | $6,725,000 | $12,069,000 | $11,987,000 | $7,735,000 |
| Current Deferred Liabilities | $2,696,000 | $1,996,000 | $3,100,000 | $2,864,000 |
| Payables And Accrued Expenses | $1,813,000 | $5,085,000 | $4,053,000 | $1,156,000 |
| Payables | $470,000 | $3,042,000 | $3,394,000 | $225,000 |
| Accounts Payable | $470,000 | $602,000 | $144,000 | $225,000 |
| Tradeand Other Payables Non Current | - | $0 | $3,330,000 | $0 |
| Other Payable | - | $2,440,000 | $3,250,000 | - |
| Equity | ||||
| Common Stock Equity | $124,801,000 | $182,431,000 | $170,029,000 | $178,248,000 |
| Total Equity Gross Minority Interest | $124,801,000 | $182,431,000 | $170,029,000 | $178,248,000 |
| Stockholders Equity | $124,801,000 | $182,431,000 | $170,029,000 | $178,248,000 |
| Gains Losses Not Affecting Retained Earnings | $-271,000 | $-251,000 | $-141,000 | $-308,000 |
| Other Equity Adjustments | $-271,000 | $-251,000 | $-141,000 | $-308,000 |
| Retained Earnings | $-34,364,000 | $30,354,000 | $25,196,000 | $40,044,000 |
| Other | ||||
| Ordinary Shares Number | $20,137,480 | $20,051,134 | $19,937,961 | $20,260,070 |
| Share Issued | $20,137,480 | $20,051,134 | $19,937,961 | $20,260,070 |
| Tangible Book Value | $51,874,000 | $27,514,000 | $118,081,000 | $139,147,000 |
| Invested Capital | $124,801,000 | $182,431,000 | $170,029,000 | $178,248,000 |
| Working Capital | $44,824,000 | $27,272,000 | $118,385,000 | $139,055,000 |
| Capital Lease Obligations | $616,000 | $1,006,000 | $1,197,000 | $1,404,000 |
| Total Capitalization | $124,801,000 | $182,431,000 | $170,029,000 | $178,248,000 |
| Additional Paid In Capital | $159,416,000 | $152,308,000 | - | - |
| Capital Stock | $20,000 | $20,000 | $144,974,000 | $138,512,000 |
| Common Stock | $20,000 | $20,000 | $144,974,000 | $138,512,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $410,000 | $531,000 | $755,000 | $943,000 |
| Current Deferred Revenue | $2,696,000 | $1,996,000 | $3,100,000 | $2,864,000 |
| Current Capital Lease Obligation | $206,000 | $475,000 | $442,000 | $461,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,010,000 | $4,513,000 | $4,392,000 | $3,254,000 |
| Current Accrued Expenses | $1,343,000 | $2,043,000 | $659,000 | $931,000 |
| Goodwill | $43,717,000 | $96,078,000 | $19,099,000 | $12,921,000 |
| Net PPE | $1,287,000 | $1,839,000 | $1,918,000 | $2,052,000 |
| Accumulated Depreciation | $-577,000 | $-603,000 | $-660,000 | $-648,000 |
| Gross PPE | $1,864,000 | $2,442,000 | $2,578,000 | $2,700,000 |
| Leases | $10,000 | $20,000 | $24,000 | $13,000 |
| Construction In Progress | $0 | $0 | $134,000 | $0 |
| Other Properties | $416,000 | $1,094,000 | $1,563,000 | $1,766,000 |
| Machinery Furniture Equipment | $1,438,000 | $1,328,000 | $857,000 | $921,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $1,500,000 | $9,944,000 | $57,940,000 | $76,668,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $14,403,000 | $9,019,000 | $17,583,000 | $13,930,000 |
| Operating Activities | ||||
| Operating Cash Flow | $18,126,000 | $13,320,000 | $21,856,000 | $17,900,000 |
| Cash Flow From Continuing Operating Activities | $18,126,000 | $13,320,000 | $21,856,000 | $17,900,000 |
| Operating Gains Losses | $-2,000 | $-105,000 | $173,000 | $-265,000 |
| Investing Activities | ||||
| Capital Expenditure | $-3,723,000 | $-4,301,000 | $-4,273,000 | $-3,970,000 |
| Investing Cash Flow | $3,562,000 | $-53,967,000 | $7,366,000 | $4,305,000 |
| Cash Flow From Continuing Investing Activities | $3,562,000 | $-53,967,000 | $7,366,000 | $4,305,000 |
| Net Other Investing Changes | $-1,227,000 | - | - | - |
| Capital Expenditure Reported | $-2,631,000 | $-3,194,000 | $-3,219,000 | $-3,151,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $0 | $-20,000,000 | $0 |
| Financing Cash Flow | $-1,146,000 | $-6,565,000 | $-23,266,000 | $-7,622,000 |
| Cash Flow From Continuing Financing Activities | $-1,146,000 | $-6,565,000 | $-23,266,000 | $-7,622,000 |
| Net Other Financing Charges | $-1,576,000 | $-2,500,000 | - | $-3,667,000 |
| Cash Dividends Paid | $0 | $-4,796,000 | $-4,809,000 | $-4,846,000 |
| Common Stock Dividend Paid | $0 | $-4,796,000 | $-4,809,000 | $-4,846,000 |
| Net Common Stock Issuance | $0 | $0 | $-20,000,000 | $0 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Income Tax Paid Supplemental Data | $1,160,000 | $5,689,000 | $3,204,000 | $3,233,000 |
| End Cash Position | $30,853,000 | $10,311,000 | $57,523,000 | $51,567,000 |
| Beginning Cash Position | $10,311,000 | $57,523,000 | $51,567,000 | $36,984,000 |
| Changes In Cash | $20,542,000 | $-47,212,000 | $5,956,000 | $14,583,000 |
| Proceeds From Stock Option Exercised | $430,000 | $731,000 | $1,543,000 | $891,000 |
| Common Stock Payments | $0 | $0 | $-20,000,000 | $0 |
| Net Investment Purchase And Sale | $8,512,000 | $49,107,000 | $19,862,000 | $8,275,000 |
| Sale Of Investment | $15,012,000 | $116,266,000 | $114,907,000 | $109,121,000 |
| Purchase Of Investment | $-6,500,000 | $-67,159,000 | $-95,045,000 | $-100,846,000 |
| Net Business Purchase And Sale | $0 | $-98,773,000 | $-8,223,000 | $0 |
| Purchase Of Business | $0 | $-98,773,000 | $-8,223,000 | $0 |
| Net Intangibles Purchase And Sale | $-379,000 | $-541,000 | $-601,000 | $0 |
| Purchase Of Intangibles | $-379,000 | $-541,000 | $-601,000 | $0 |
| Net PPE Purchase And Sale | $-713,000 | $-566,000 | $-453,000 | $-819,000 |
| Purchase Of PPE | $-713,000 | $-566,000 | $-453,000 | $-819,000 |
| Change In Working Capital | $-2,586,000 | $-4,212,000 | $5,103,000 | $-2,620,000 |
| Change In Other Working Capital | $700,000 | $-2,560,000 | $176,000 | $2,213,000 |
| Change In Other Current Liabilities | $-3,187,000 | $-768,000 | $832,000 | $-1,437,000 |
| Change In Payables And Accrued Expense | $-132,000 | $-477,000 | $-88,000 | $-162,000 |
| Change In Payable | $-132,000 | $-477,000 | $-88,000 | $-162,000 |
| Change In Account Payable | $-132,000 | $-477,000 | $-81,000 | $-162,000 |
| Change In Tax Payable | $0 | $0 | $-7,000 | $0 |
| Change In Income Tax Payable | $0 | $0 | $-7,000 | $0 |
| Change In Prepaid Assets | $614,000 | $-3,536,000 | $86,000 | $702,000 |
| Change In Receivables | $-581,000 | $3,129,000 | $4,097,000 | $-3,936,000 |
| Changes In Account Receivables | $-581,000 | $3,129,000 | $4,097,000 | $-3,936,000 |
| Other Non Cash Items | $-864,000 | $-1,639,000 | $680,000 | $283,000 |
| Stock Based Compensation | $6,354,000 | $6,538,000 | $4,828,000 | $3,037,000 |
| Asset Impairment Charge | $77,221,000 | $0 | $500,000 | $0 |
| Amortization Of Securities | $-64,000 | $-1,116,000 | $-1,134,000 | $1,678,000 |
| Deferred Tax | $-5,426,000 | $-1,765,000 | $-2,095,000 | $-270,000 |
| Deferred Income Tax | $-5,426,000 | $-1,765,000 | $-2,095,000 | $-270,000 |
| Depreciation Amortization Depletion | $8,211,000 | $5,665,000 | $3,840,000 | $3,574,000 |
| Depreciation And Amortization | $8,211,000 | $5,665,000 | $3,840,000 | $3,574,000 |
| Net Foreign Currency Exchange Gain Loss | $-25,000 | $-105,000 | $167,000 | $-265,000 |
| Net Income From Continuing Operations | $-64,718,000 | $9,954,000 | $9,961,000 | $12,483,000 |
| Sale Of Business | - | - | - | $0 |
| Change In Accrued Expense | - | - | - | - |
Fetched: 2026-06-18